Fungal Allergy as Yet Unsolved

  • Robert K. Bush
Part of the Allergy Frontiers book series (ALLERGY, volume 3)


Allergy Clin Immunol Aspergillus Fumigatus Alternaria Alternata Allergy Asthma Immunol Allergic Bronchopulmonary Aspergillosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blackley C. Experimental Researches on the Causes of Catarrhus Aestivus (Hay Fever or Hay Asthma). London: Bailliere Tindal & Cox; 1873.Google Scholar
  2. 2.
    Esch RE, Bush RK. Aerobiology of outdoor allergens. In: Adkinson, editors. Middleton's Allergy: Principles and Practice. St. Louis, MO: Mosby; 2003.Google Scholar
  3. 3.
    Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics 2006;7:251.PubMedCrossRefGoogle Scholar
  4. 4.
    Bowyer P, Denning DW. Genomic analysis of allergen genes in Aspergillus spp: the relevance of genomics to everyday research. Med Mycol 2007;45:17–26.PubMedCrossRefGoogle Scholar
  5. 5.
    Friedlander SL, Bush RK. Fungal allergy. In: Kurup, V, editors. Mold Allergy, Biology and Pathogenesis. Kerala, India: Research Signpost; 2005. pp. 1–15.Google Scholar
  6. 6.
    Portnoy J, Barnes C, Barnes CS. The National Allergy Bureau: pollen and spore reporting today. J Allergy Clin Immunol 2004;114:1235–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Portnoy JM, Barnes CS, Kennedy K. Sampling for indoor fungi. J Allergy Clin Immunol 2004;113:189–98.PubMedCrossRefGoogle Scholar
  9. 9.
    Joint Task Force. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol 2003;90:1–40.Google Scholar
  10. 10.
    Horner WE, Barnes C, Cohn RD, Levetin E. Guide for interpreting reports from inspections/ identifications of indoor molds. J Allergy Clin Immunol 2008; 121:592–97.PubMedCrossRefGoogle Scholar
  11. 11.
    Salo PM, Arbes SJ Jr, Cohn RD, Burge HA, London SJ, Zeldin DC. Alternaria alternata antigens in US homes. J Allergy Clin Immunol 2006;117:473.PubMedCrossRefGoogle Scholar
  12. 12.
    Barnes C, Portnoy J, Sever M, Arbes S Jr, Vaughn B, Zeldin DC. Comparison of enzyme immunoassay-based assays for environmental Alternaria alternata. Ann Allergy Asthma Immunol 2006;97:350–6.PubMedGoogle Scholar
  13. 13.
    Beijer L, Rylander R. (1 – > 3)-beta-D-glucan does not induce acute inflammation after nasal deposition. Mediators Inflamm 2005;2005(1):50–2.PubMedCrossRefGoogle Scholar
  14. 14.
    Douwes J. (1 – > 3)-Beta-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 2005;15:160–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Yamada J, Hamuro J, Hatanaka H, Hamabata K, Kinoshita S. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study. J Allergy Clin Immunol 2007;119:1119–26.PubMedCrossRefGoogle Scholar
  16. 16.
    Iossifova Y Y, Reponen T, Bernstein DI, Levin L, Kalra H, Campo P, et al. House dust (1–3)-beta-D-glucan and wheezing in infants. Allergy 2007;62:504–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA. The medical effects of mold exposure. J Allergy Clin Immunol 2006;117:326–33.PubMedCrossRefGoogle Scholar
  18. 18.
    Portnoy JM, Kennedy K, Barnes C. Sampling for indoor fungi: what the clinician needs to know. Curr Opin Otolaryngol Head Neck Surg 2005;13:165–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Kurup VP. Fungal allergens. Curr Allergy Asthma Rep 2003;3:416–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Vijay HM, Abebe M, Kurup VP. Alternaria and Cladosporium allergens and allergy. In: Kurup, VP (ed) Mold Allergy, Biology and Pathogenesis. Kerala, India: Research Signpost; 2005, pp. 51–68.Google Scholar
  21. 21.
    Singh BP, Kukreja N, Arora N. Clinically relevant allergens from fungi imperfecti and yeast. In: Kurup, VP (ed) Mold Allergy, Biology and Pathogenesis. Kerala, India: Research Signpost; 2005, pp. 77–92.Google Scholar
  22. 22.
    Esch RE. Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004;113:210–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M. Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allergy Clin Immunol 2001;107:641–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Huss K, Adkinson NF Jr, Eggleston PA, Dawson C, Van Natta ML, Hamilton RG. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol 2001;107:48–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Arbes SJ Jr, Cohn RD, Yin M, Muilenberg ML, Friedman W, Zeldin DC. Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: results from the National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 2004;114:111–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Arbes SJ Jr, Sever M, Mehta J, Gore JC, Schal C, Vaughn B, et al. Abatement of cockroach allergens (Bla g 1 and Bla g 2) in low-income, urban housing: month 12 continuation results. J Allergy Clin Immunol 2004;113:109–14.PubMedCrossRefGoogle Scholar
  27. 27.
    Chew GL, Higgins KM, Gold DR, Muilenberg ML, Burge HA. Monthly measurements of indoor allergens and the influence of housing type in a northeastern US city. Allergy 1999;54:1058–66.PubMedCrossRefGoogle Scholar
  28. 28.
    Salo PM, Arbes SJ, Jr., Sever M, Jaramillo R, Cohn RD, London SJ, et al. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J Allergy Clin Immunol 2006;118:892–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Sporik RB, Arruda LK, Woodfolk J, Chapman MD, Platts-Mills TA. Environmental exposure to Aspergillus fumigatus allergen (Asp f I). Clin Exp Allergy 1993;23:326–31.PubMedCrossRefGoogle Scholar
  30. 30.
    Green BJ, Yli-Panula E, Tovey ER. Halogen immunoassay, a new method for the detection of sensitization to fungal allergens; comparisons with conventional techniques. Allergol Int 2006;55:131–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Terr AI. Are indoor molds causing a new disease? J Allergy Clin Immunol 2004;113:221–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Update: pulmonary hemorrhage/hemosiderosis among infants – Cleveland, Ohio, 1993–1996. MMWR Morb Mortal Wkly Rep 2000;49:180–4.Google Scholar
  33. 33.
    Brown CM, Redd SC, Damon SA. Acute idiopathic pulmonary hemorrhage among infants. Recommendations from the Working Group for Investigation and Surveillance. MMWR Recomm Rep 2004;53:1–12.Google Scholar
  34. 34.
    Portnoy JM, Kennedy K, Barnes CS. Controversies regarding dampness and mold growth in homes. Allergy Asthma Proc 2007;28:257–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Hope AP, Simon RA. Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc 2007;28:262–70.PubMedCrossRefGoogle Scholar
  36. 36.
    Andes D, Proctor R, Bush RK, Pasic TR. Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis. Clin Infect Dis 2000;31:202–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004;64:363–74.PubMedCrossRefGoogle Scholar
  38. 38.
    Marple BF, Gibbs SR, Newcomer MT, Mabry RL. Allergic fungal sinusitis-induced visual loss. Am J Rhinol 1999;13:191–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004;114:1369–75.PubMedCrossRefGoogle Scholar
  40. 40.
    Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005;175:5439–47.PubMedGoogle Scholar
  41. 41.
    Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005;115:125–31.PubMedCrossRefGoogle Scholar
  42. 42.
    Bush RK. Is topical antifungal therapy effective in the treatment of chronic rhinosinusitis? J Allergy Clin Immunol 2005;115:123–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Lehrer SB, Hughes JM, Altman LC, Bousquet J, Davies RJ, Gell L, et al. Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy 1994;49:460–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997;155:1356–61.PubMedGoogle Scholar
  45. 45.
    Perzanowski MS, Sporik R, Squillace SP, Gelber LE, Call R, Carter M, et al. Association of sensitization to Alternaria allergens with asthma among school-age children. J Allergy Clin Immunol 1998;101:626–32.PubMedCrossRefGoogle Scholar
  46. 46.
    Downs SH, Mitakakis TZ, Marks GB, Car NG, Belousova EG, Leuppi JD, et al. Clinical importance of Alternaria exposure in children. Am J Respir Crit Care Med 2001;164:455–9.PubMedGoogle Scholar
  47. 47.
    Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for lifethreatening asthma. Allergy 2000;55:501–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Dales RE, Cakmak S, Burnett RT, Judek S, Coates F, Brook JR. Influence of ambient fungal spores on emergency visits for asthma to a regional children's hospital. Am J Respir Crit Care Med 2000;162:2087–90.PubMedGoogle Scholar
  49. 49.
    Pulimood T, Corden J, Bryden C, Sharples L, Nasser S. Epidemic asthma and the role of the fungal mould Alternaria alternata. J Allergy Clin Immunol 2007; 610–7.Google Scholar
  50. 50.
    Marks GB, Bush RK. It's blowing in the wind (editorial). J Allergy Clin Immunol 2007;120:530–2.PubMedCrossRefGoogle Scholar
  51. 51.
    Targonski P V, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955–61.PubMedCrossRefGoogle Scholar
  52. 52.
    Reed CE. Inflammatory effect of environmental proteases on airway mucosa. Current Allergy Reports 2007;7:368–374.CrossRefGoogle Scholar
  53. 53.
    Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185–93.PubMedCrossRefGoogle Scholar
  54. 54.
    Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904–11.PubMedGoogle Scholar
  55. 55.
    Greenberger PA. Allergic bronchopulmonary Aspergillosis – clinical aspects. In: Kurup, VP (ed) Mold Allergy, Biology and Pathogenesis. Kerala, India: Research Signpost; 2005.Google Scholar
  56. 56.
    Virnig C, Bush RK. Allergic bronchopulmonary aspergillosis: a US perspective. Curr Opin Pulm Med 2007;13:67–71.PubMedCrossRefGoogle Scholar
  57. 57.
    Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685–92.PubMedCrossRefGoogle Scholar
  58. 58.
    Stevens DA, Schwartz HJ, Lee J Y, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756–62.PubMedCrossRefGoogle Scholar
  59. 59.
    Peat JK, Dickerson J, Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy 1998;53:120–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Verhoeff AP, Burge HA. Health risk assessment of fungi in home environments. Ann Allergy Asthma Immunol 1997;78:544–54.PubMedGoogle Scholar
  61. 61.
    Douwes J, Pearce N. Invited commentary: is indoor mold exposure a risk factor for asthma? Am J Epidemiol 2003;158:203–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Trout DB, Page EH. Fungal exposure and lower respiratory illness in children. Am J Respir Crit Care Med 2004;169:969–70.PubMedGoogle Scholar
  63. 63.
    Stark PC, Burge HA, Ryan LM, Milton DK, Gold DR. Fungal levels in the home and lower respiratory tract illnesses in the first year of life. Am J Respir Crit Care Med 2003;168:232–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Board of Health Promotion and Disease Prevention CoDISaH (2004) Damp indoor spaces and health. Washington, DC: Institute of Medicine of the National Academies.Google Scholar
  65. 65.
    Kim JL, Elfman L, Mi Y, Wieslander G, Smedje G, Norback D. Indoor molds, bacteria, microbial volatile organic compounds and plasticizers in schools – associations with asthma and respiratory symptoms in pupils. Indoor Air 2007;17:153–63.PubMedCrossRefGoogle Scholar
  66. 66.
    Terr AI. Clinical ecology. J Allergy Clin Immunol 1987;79:423–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Emanuel DA, Wenzel FJ, Lawton BR. Pulmonary mycotoxicosis. Chest 1975;67:293–7.PubMedCrossRefGoogle Scholar
  68. 68.
    Khalili B, Montanaro MT, Bardana EJ Jr. Inhalational mold toxicity: fact or fiction? A clinical review of 50 cases. Ann Allergy Asthma Immunol 2005;95:239–46.PubMedCrossRefGoogle Scholar
  69. 69.
    Mahmoudi M, Gershwin ME. Sick building syndrome. III. Stachybotrys chartarum. J Asthma 2000;37:191–8.Google Scholar
  70. 70.
    Hossain MA, Ahmed MS, Ghannoum MA. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol 2004;113:200–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Rabito FA, Iqbal S, Kiernan MP, Hold E, Chew GL. Children's respiratory health and mold levels in New Orleans post-Katrina: a preliminary look. J Allergy Clin Immunol 2008;121:622–5.PubMedCrossRefGoogle Scholar
  72. 72.
    Bush RK, Yunginger JW. Standardization of fungal allergens. Clin Rev Allergy 1987;5:3–21.PubMedGoogle Scholar
  73. 73.
    Bush RK. Fungal extracts in clinical practice. Allergy Proc 1993;14:385–90.PubMedCrossRefGoogle Scholar
  74. 74.
    Helm RM, Squillace DL, Aukrust L, Borch SM, Baer H, Bush RK, et al. Production of an international reference standard alternaria extract. I. Testing of candidate extracts. Int Arch Allergy Appl Immunol 1987;82:178–89.Google Scholar
  75. 75.
    Helm RM, Squillace DL, Yunginger JW. Production of a proposed international reference standard Alternaria extract. II. Results of a collaborative trial. J Allergy Clin Immunol 1988;81:651–63.Google Scholar
  76. 76.
    Eggleston PA. Environmental control for fungal allergen exposure. Curr Allergy Asthma Rep 2003;3:424–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Maloney MJ, Wray BB, DuRant RH, Smith L, Smith L. Effect of an electronic air cleaner and negative ionizer on the population of indoor mold spores. Ann Allergy 1987;59:192–4.PubMedGoogle Scholar
  78. 78.
    Li JT, Pearlman DS, Nicklas RA, Lowenthal M, Rosenthal RR, Bernstein IL, et al. Algorithm for the diagnosis and management of asthma: a practice parameter update: Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:415–20.PubMedCrossRefGoogle Scholar
  79. 79.
    Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460–72.PubMedCrossRefGoogle Scholar
  80. 80.
    Dreborg S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131–40.Google Scholar
  81. 81.
    Malling HJ, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986;41:507–19.Google Scholar
  82. 82.
    Bernardis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 1996;6:55–62.PubMedGoogle Scholar
  83. 83.
    Delfino RJ, Coate BD, Zeiger RS, Seltzer JM, Street DH, Koutrakis P. Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores. Am J Respir Crit Care Med 1996;154:633–41.PubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Robert K. Bush
    • 1
    • 2
    • 3
  1. 1.Professor, Department of Medicine, Section of Allergy/Immunology, Pulmonary and Clinical Care MedicineUniversity of WisconsinMadisonUSA
  2. 2.Chief of Allergy, Wm. S. Middleton VA HospitalMadisonUSA
  3. 3.K4/910 CSCMadisonUSA

Personalised recommendations